Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison May 28, 2021 3:16pm
255 Views
Post# 33287854

RE:Gotta believe good news coming soon

RE:Gotta believe good news coming soonnewdaydawning wrote
Today's bullish action suggests some upbeat data from the Ph2 NMIBC trial is coming. If all 3 pending read-outs reach 90-day CR, then we hit 5-out-of-6 at that critical juncture.

Been a great week for TLT, allowing for greater indulgence this week-end. GLTA


Right newdaydawning very bullish week, no doubt we will see exciting data either on perhaps patients 16 and 17 for 90 day CR, I think it might be too early for patient #18 on the 90 day but let's hope. Then with Covid-19 cases dropping both sides of the border my opinion is the month of May could have 3 to 7 new patients treated, yes 7 is a big stretch and if we do see 7 then that gives Theralase (TLT) the magic number 25. My biased opinion of course is if we see CR (complete response) in most of the remaining patients for the 25 then it will remain CR after 180 through to the 1 year! 

My speculation in regards to Short Form Prospectus is confidence by the company  that NMIBC will be successful and eagerly wanting to tackle Lung and Brain with Covid-19 for the big touchdown. 
<< Previous
Bullboard Posts
Next >>